Concurrent chemoradiotherapy using gemcitabine and nedaplatin in recurrent or locally advanced head and neck squamous cell carcinoma

BACKGROUND: Patients with recurrent or locally advanced head and neck squamous cell carcinoma (HNSCC) typically have limited treatment options and poor prognosis. AIM: To evaluate the efficacy and safety of two drugs with potent radio-sensitization properties including gemcitabine and nedaplatin as...

Descripción completa

Detalles Bibliográficos
Autores principales: Huo, Rui-Xue, Jin, Ying-Ying, Zhuo, Yong-Xue, Ji, Xiao-Tong, Cui, Yu, Wu, Xiao-Jing, Wang, Yi-Jia, Zhang, Long, Zhang, Wen-Hua, Cai, Yu-Mei, Zheng, Cheng-Cheng, Cui, Rui-Xue, Wang, Qian-Ye, Sun, Zhen, Wang, Feng-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048568/
https://www.ncbi.nlm.nih.gov/pubmed/35611190
http://dx.doi.org/10.12998/wjcc.v10.i11.3414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9048568/
https://www.ncbi.nlm.nih.gov/pubmed/35611190
http://dx.doi.org/10.12998/wjcc.v10.i11.3414

Ejemplares similares